N@N

Fibrocell Science, Inc. to Present at the Maxim Group Growth Conference

_{//health-fitness.news-articles.net/content/2010/ .. resent-at-the-maxim-group-growth-conference.html}
^{Published in Health and Fitness on Wednesday, November 10th 2010 at 5:16 GMT by Market Wire}  

EXTON, Pa.--([ BUSINESS WIRE ])--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that David M. Pernock, the Companya™s Chairman and CEO, will be presenting at the Maxim Group Growth Conference to be held on Thursday, November 18, 2010, at The Grand Hyatt Hotel in New York.

Fibrocella™s presentation is scheduled for 3:30 p.m. Eastern Time.

The audio portion of the presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at [ www.fibrocellscience.com ].

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. For additional information, please visit [ www.fibrocellscience.com ].